Squarepoint’s Enfusion, Inc. ENFN Stock Holding History

Squarepoint’s Portfolio ENFN Stock Details ENFN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-166,270	Closed	-$1.85M	–	5223
2025 Q1	$1.85M	Buy	166,270 +130,637	+367%	+$1.44M	﹤0.01%	2155
2024 Q4	$367K	Buy	35,633 +20,550	+136%	+$199K	﹤0.01%	4002
2024 Q3	$143K	Sell	15,083 -65,043	-81%	-$561K	﹤0.01%	3791
2024 Q2	$683K	Buy	+80,126	New	+$733K	﹤0.01%	2844
2023 Q1	–	Sell	-18,607	Closed	-$180K	–	3923
2022 Q4	$180K	Buy	+18,607	New	+$210K	﹤0.01%	2825
2022 Q1	–	Sell	-53,244	Closed	-$1.11M	–	3654
2021 Q4	$1.11M	Buy	+53,244	New	+$1.08M	﹤0.01%	1628

Other funds holding ENFN

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Squarepoint's ENFN Position: Q2 2025 in Review

Squarepoint sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 166,270 shares — an estimated $1.85M sold.

Squarepoint first reported a position in ENFN in Q4 2021 and held it in 6 quarters. The position peaked at $1.85M in Q1 2025. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

Squarepoint reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
Squarepoint sold 166,270 Enfusion, Inc. shares in Q2 2025, an estimated $1.85M.
Squarepoint first reported a position in Enfusion, Inc. in Q4 2021 and held it in 6 quarters.
Squarepoint's Enfusion, Inc. position peaked at $1.85M in Q1 2025.
2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Squarepoint's 13F filing for Q2 2025, filed 14 Aug 2025.